Posts Tagged ‘MD’

Research study aims to understand inherited lung cancer gene

Posted: Oct 30, 2013 | Posted by Kassy Perry | Comments Off on Research study aims to understand inherited lung cancer gene

INHERIT EGFR study expands to second site

San Carlos, Calif. (October 30, 2013)– A new research study, funded by the Bonnie J. Addario Lung Cancer Foundation (ALCF), is aiming to understand how an inherited gene in some lung cancer patients could serve as an early detection screening for family members.

“We’re hoping this study provides new insight for methods to screen for lung cancer in people who might not have otherwise qualified for screening: the family members of lung cancer patients,” said Bonnie J. Addario, lung cancer survivor and founder of the ALCF. “And we also hope to show that lung cancer doesn’t just affect people who smoke.”

The INHERIT (Investigating Hereditary Risk from T790M) research study, facilitated by the Addario Lung Cancer Medical Institute (ALCMI), is the first to apply inherited familial genetics – widely used to assess risk for breast and colon cancer – to provide insight into lung cancer. Dr. Geoffrey Oxnard and a team of physicians at Dana-Farber/Brigham and Women’s Cancer Center in Boston, MA are leading the INHERIT study to understand whether the presence of the T790M gene mutation in lung cancers is associated with an inherited gene alteration. Oxnard’s team will also examine whether having the inherited form of T790M raises the risk of lung cancer in patients and families. The ALCMI study was launched at Dana-Farber and has now expanded to include Vanderbilt-Ingram Cancer Center in Nashville, Tenn. No travel is required to participate.

***Media Advisory*** The Bonnie J. Addario Lung Cancer Foundation Presents The Living Room

Posted: Mar 19, 2013 | Posted by Kassy Perry | No Comments

The nation’s premiere live-streamed lung cancer support group for patients and family

WHAT: The Bonnie J. Addario Lung Cancer Foundation invites you to join The Living Room, a lively and special support group for those who are directly and indirectly affected by lung cancer. The Living Room takes place the third Tuesday of every month and is live-streamed online. It is the nation’s premier lung cancer support group for lung cancer patients and their families, offering expert opinion and advice not found anywhere else.

WHERE: Visit

WHO: The Lung Cancer Foundation is truly honored to host Geoffrey Oxnard, MD, a world-renown medical oncologist and researcher at the prestigious Dana Farber Cancer Institute in Boston. He has devoted his career to caring for and treating lung cancer patients and researching and implementing better ways of understanding and treating the disease. His current ground-breaking research includes a study of familial lung cancer due to inherited EGFR mutations and a study of young adult lung cancer, both of which are collaborations with the Addario Lung Cancer Medical Institute. For Dr. Oxnard’s full bio, CLICK HERE.

WHEN: Tuesday, March 19, 2013
5:30 – 7:30 p.m. (PST)

WHY: When patients have questions about lung cancer, when they have something they want to talk about, when they need advice from someone who has been there before or from experts who can help, patients don’t have to go far – they just have to go to The Living Room.

VISUALS: The set up is just like a living room.

  • Patients and family all gather around
  • Appetizers and beverages are served
  • Participants listen and interact with leading experts and thought leaders in the field of lung cancer treatment and research

About the Bonnie J. Addario Lung Cancer Foundation

The Bonnie J. Addario Lung Cancer Foundation is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. BJALCF was established on March 6, 2006 as a 501c(3) non-profit organization and has raised more than $9 million for lung cancer research.